TMCnet News
Blueberries Medical Announces $3 Million Non-Brokered Private PlacementTORONTO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces a non-brokered private placement of up to 12,000,000 units (the “Units”) at a price of C$0.25 per Unit for gross proceeds of up to C$3,000,000 (the “Offering”). Each Unit will consist of one common share in the capital of the Company (a “Share”) and one Share purchase warrant (a “Warrant”). Each Warrant shall entitle the holder to acquire one Share at a price of C$0.35 for a period of 24 months following the completion of the Offering. Closing of the Offering is expected to occur on or about August 27, 2019. A 7% finder’s fee will be payable in cash in respect of subscriptions sourced by eligible finders, together with the issuance of finder warrants (the “Finder Warrants”) equal to 7% of the Units placed by eligible finders in connection the Offering. Each Finder Warrant shall entitle the holder to acquire one Unit for C$0.25 for a period of 24 months following the completion of the Offering. The net proceeds from the sale of the Units will be used to expand the business of the Company, and for working capital and general corporate purposes. About Blueberries Medical Corp. Additional information about the Company is available at www.blueberriesmed.om. For more information, please contact: Camilo Villalba, Chief Operating Officer Ian Atacan, Chief Financial Officer Jessika Angarita, Pacta Relations Cautionary Note Regarding Forward-Looking Information These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Colombian and international medical cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in Colombia, Argentina and elsewhere; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law. Additional information regarding the Company, and other risks and uncertainties relating to the Company's business are contained under the heading “Risk Factors” in the Company's Listing Statement dated January 31, 2019 filed on its issuer profile on SEDAR at www.sedar.com. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. |